Mechanical forces and TGFβ1 reduce podocyte adhesion through α3β1 integrin downregulation

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2645-2655

  Dessapt, Cecile ^a   Baradez, Marc Olivier ^b   Hayward, Anthea ^a   Dei Cas, Alessandra ^a   Thomas, Stephen M ^a   Viberti, Giancarlo ^a   Gnudi, Luigi ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

3 1 integrin; Cell adhesion; Podocyte; Stretch; TGF 1

Indexed keywords

CASPASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VERY LATE ACTIVATION ANTIGEN 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; DOWN REGULATION; EXTRACELLULAR MATRIX; MECHANICAL STRESS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DRUG EFFECT; GLOMERULUS BASEMENT MEMBRANE; GLYCOSYLATION; KIDNEY DISEASE; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL ADHESION; CELLS, CULTURED; DOWN-REGULATION; EXTRACELLULAR MATRIX; GLOMERULAR BASEMENT MEMBRANE; GLYCOSYLATION; INTEGRIN ALPHA3BETA1; KIDNEY DISEASES; MICE; PODOCYTES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STRESS, MECHANICAL; TRANSFORMING GROWTH FACTOR BETA1;

EID: 69249117313     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp204     Document Type: Article

References (57)

1. Osterby R, Gundersen HJ, Horlyck A et al. Diabetic glomerulopathy. Structural characteristics of the early and advanced stages. Diabetes 1983; 32(Suppl 2): 79-82
2. Miner JH. Renal basement membrane components. Kidney Int 1999; 56: 2016-2024
3. Farquhar MG. Editorial. The primary glomerular filtration barrier-basement membrane or epithelial slits? Kidney Int 1975; 8: 197-211
4. Wharram BL, Goyal M, Wiggins JE et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16: 2941-2952
5. Petermann AT, Pippin J, Krofft R et al. Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol 2004; 98: e114-e123
6. Pagtalunan ME, Miller PL, Jumping-Eagle S et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348
7. Steffes MW, Schmidt D, McCrery R et al. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001; 59: 2104-2113
8. White KE, Bilous RW, Marshall SM et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002; 51: 3083-3089
9. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147
10. Marshall CB, Shankland SJ. Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol 2007; 106: e51-e59
11. Verzola D, Gandolfo MT, Ferrario F et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007; 72: 1262-1272
12. Isermann B, Vinnikov IA, Madhusudhan T et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 2007; 13: 1349-1358
13. Vogelmann SU, Nelson WJ, Myers BD et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285: F40-F48
14. Grossmann J. Molecular mechanisms of 'detachment-induced apoptosis-Anoikis'. Apoptosis 2002; 7: 247-260
15. Chen CA, Tsai JC, Su PW et al. Signaling and regulatory mechanisms of integrinalpha3beta1 on the apoptosis of cultured rat podocytes. J Lab Clin Med 2006; 147: 274-280
16. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5
17. Korhonen M, Ylanne J, Laitinen L et al. The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol 1990; 111: 1245-1254
18. PateyN,Halbwachs-Mecarelli L, DrozDet al.Distribution of integrin subunits in normal human kidney. Cell Adhes Commun 1994; 2: 159-167
19. Kerjaschki D, Ojha PP, Susani M et al. A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol 1989; 134: 481-489
20. Kreidberg JA. Functions of alpha3beta1 integrin. Curr Opin Cell Biol 2000; 12: 548-553
21. Bellis SL. Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim Biophys Acta 2004; 1663: 52-60
22. Koivisto L, Heino J, Hakkinen L et al. The size of the intracellular beta 1-integrin precursor pool regulates maturation of beta 1-integrin subunit and associated alpha-subunits. Biochem J 1994; 300 (Pt 3): 771-779
23. von Lampe B, Stallmach A, Riecken EO. Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut 1993; 34: 829-836
24. Adler S. Characterization of glomerular epithelial cell matrix receptors. Am J Pathol 1992; 141: 571-578
25. Kreidberg JA,DonovanMJ, Goldstein SL et al.Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 1996; 122: 3537-3547
26. Regoli M, Bendayan M. Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia 1997; 40: 15-22
27. Chen HC, Chen CA, Guh JY et al. Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes. Life Sci 2000; 67: 2345-2353
28. Chen CA, Hwang JC, Guh JY et al. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. J Lab Clin Med 2006; 147: 74-82
29. Kolm-Litty V, Sauer U, Nerlich A et al. High glucose induced transforming growth factor beta 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cell. J Clin Invest 1998; 101: 160-169
30. Burt DJ, Gruden G, Thomas SM et al. P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 2003; 46: 531-537
31. Gruden G, Zonca S, Hayward A et al. Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 2000; 49: 655-661
32. Jung KY, Chen K, Kretzler M et al. TGF-beta1 regulates the PINCH-1-integrin-linked kinase-alpha-parvin complex in glomerular cells. J Am Soc Nephrol 2007; 18: 66-73
33. Wu DT, Bitzer M, JuWet al. TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol 2005; 16: 3211-3221
34. Mundel P, Reiser J, Borja AZ et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
35. Kikkawa Y, Sanzen N, Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. Laminin-10/11 mediates cell adhesion through integrin alpha3 beta1. J Biol Chem 1998; 273: 15854-15859
36. Riser BL, Cortes P, Zhao X et al. Intraglomerular pressure andmesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90: 1932-1943
37. van EM, Nieland LJ, Ramaekers FC et al. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31: 1-9
38. Varghese J, Khandre NS, Sarin A. Caspase-3 activation is an early event and initiates apoptotic damage in a human leukemia cell line. Apoptosis 2003; 8: 363-370
39. Collins JA, Schandi CA, Young KK et al. Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 1997; 45: 923-934
40. White KE, Bilous RW. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 2004; 19: 1437-1440
41. Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002; 57: 247-253
42. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005; 54: 1626-1634
43. Kumar CC. Signaling by integrin receptors. Oncogene 1998; 17: 1365-1373
44. Kitsiou PV, Tzinia AK, Stetler-Stevenson WGet al. Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2003; 284: F671-F679
45. Regoli M, Bendayan M. Expression of beta1 integrins in glomerular tissue of streptozotocin-induced diabetic rats. BiochemCell Biol 1999; 77: 71-78
46. Bellis SL, Newman E, Friedman EA. Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras. J Cell Physiol 1999; 181: 33-44
47. Heino J, Massague J. Transforming growth factor-beta switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J Biol Chem 1989; 264: 21806-21811
48. Akiyama SK, Yamada SS, Yamada KM. Analysis of the role of glycosylation of the human fibronectin receptor. J Biol Chem1989; 264: 18011-18018
49. Zheng M, Fang H, Hakomori S. Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem 1994; 269: 12325-12331
50. Heino J, Ignotz RA, Hemler ME et al. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem 1989; 264: 380-388
51. Mooney A, Jackson K, Bacon R et al. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals. Am J Pathol 1999; 155: 599-606
52. Park CC, Zhang H, Pallavicini M et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 2006; 66: 1526-1535
53. Zhang H, Ozaki I, Mizuta T et al. Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogenactivated protein kinase activation in human hepatoma cells. Cancer Sci 2004; 95: 878-886
54. Durvasula RV, Petermann AT, Hiromura K et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65: 30-39
55. Grossmann J, Walther K, Artinger M et al. Apoptotic signaling during initiation of detachment-induced apoptosis ('anoikis') of primary human intestinal epithelial cells. Cell Growth Differ 2001; 12: 147-155
56. Chen S, Lee JS, Iglesias-De La Cruz MC et al. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGFbeta and VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 2005; 20: 1320-1328
57. Iglesias-De La Cruz MC, Ziyadeh FN, Isono M et al. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 2002; 62: 901-913